pharma · Head and Neck Squamous Cell Carcinoma · Metastatic Head and Neck Squamous Cell Carcinoma · BCAX
Bicara Therapeutics
NovaPharmaNews editorial coverage mentioning Bicara Therapeutics — regulatory, clinical, and market analysis.
Boston, USA HQ
2020 Founded
115 Employees
Public company Type
BCAX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2020
- Employees
- 115
- Programs
- 6
- Drugs
- 4
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Bicara Therapeutics — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Bicara Therapeutics — regulatory, clinical, and market analysis.
